CEO and Founder, has extensive experience in Medical Device Sector, Health Care Sector, National Public Health Care system, advisor for Pharmaceutical Companies and more than 10-year experience in clinical practice.
Agronomist (Universidad Politécnica de Madrid, 1998-2005), EMBA by the IESE Business School (Madrid, 2012) and currently pursuing a master's degree in European Patent Law from the School of Industrial Organization (2018-2020). At NH81 SL is the financial advisor
Bachelor of Medicine and Surgery (University of Seville, 2003-2009) and specialist in Dermatology. Author of 20 ISI publications, 4 book chapters. Currently working on research lines related to skin cancer at the Hospital de Manises. In NH81 SL is responsible for monitoring and generating medical algorithms to give rise to biomarkers
Graduated in Biochemistry from the University of Seville (2010-2015) and master’s in molecular biology applied to a biotechnology company, with a specialization in Project Management and Management from the University of Granada (2015-2016). He began his training in project management at the company Biomedal SL, where he participated in the development of both national (CDTI and interconnecta) and international (H2020) proposals. In NH81 SL, she is responsible for the integration, management and direction of the different segments that make up the company's projects.
Electronic Industrial Engineer (E.T.S.E University of Valencia 2010-2016). During the Final Project, he developed a cardiac stimulator for electrophysiological applications. At NH81 SL, he is responsible for image processing and analysis, developing new general health biomarkers, within the Psoriasis / inflammation project, that can be easily incorporated into the FACE workflow.
Telecommunications Engineer (Universidad Politecnica de Valencia, 2012-2016) and Master in Telecommunications (2016-2018). During the Final Master Project, he developed an algorithm to find the correct position of the atria within the torso and improve the treatment of atrial fibrillation. At NH81 SL, he is responsible for processing and analyzing images by developing new biomarkers for early detection of skin cancer, which can be easily incorporated into the FACE workflow.